WO2003000277A3 - Antimicrobial peptides - Google Patents
Antimicrobial peptides Download PDFInfo
- Publication number
- WO2003000277A3 WO2003000277A3 PCT/CA2002/000936 CA0200936W WO03000277A3 WO 2003000277 A3 WO2003000277 A3 WO 2003000277A3 CA 0200936 W CA0200936 W CA 0200936W WO 03000277 A3 WO03000277 A3 WO 03000277A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amino acid
- sequence
- gram
- antimicrobial peptides
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/481,286 US20040235745A1 (en) | 2001-06-22 | 2002-06-21 | Antimicrobial Peptides |
JP2003506921A JP2004534084A (en) | 2001-06-22 | 2002-06-21 | Antimicrobial peptide |
CA2451310A CA2451310C (en) | 2001-06-22 | 2002-06-21 | Antimicrobial peptides |
EP02744972A EP1401478A2 (en) | 2001-06-22 | 2002-06-21 | Antimicrobial peptides |
AU2002317071A AU2002317071B2 (en) | 2001-06-22 | 2002-06-21 | Antimicrobial peptides |
IL15927402A IL159274A0 (en) | 2001-06-22 | 2002-06-21 | Antimicrobial peptides |
US11/761,117 US20080234188A1 (en) | 2001-06-22 | 2007-06-11 | Antimicrobial Peptides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29972601P | 2001-06-22 | 2001-06-22 | |
US60/299,726 | 2001-06-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/761,117 Continuation US20080234188A1 (en) | 2001-06-22 | 2007-06-11 | Antimicrobial Peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003000277A2 WO2003000277A2 (en) | 2003-01-03 |
WO2003000277A3 true WO2003000277A3 (en) | 2003-05-01 |
Family
ID=23156022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2002/000936 WO2003000277A2 (en) | 2001-06-22 | 2002-06-21 | Antimicrobial peptides |
Country Status (9)
Country | Link |
---|---|
US (2) | US20040235745A1 (en) |
EP (1) | EP1401478A2 (en) |
JP (1) | JP2004534084A (en) |
CN (1) | CN1516598A (en) |
AU (1) | AU2002317071B2 (en) |
CA (1) | CA2451310C (en) |
IL (1) | IL159274A0 (en) |
WO (1) | WO2003000277A2 (en) |
ZA (1) | ZA200309580B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5010798B2 (en) * | 2001-10-03 | 2012-08-29 | プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ | Copolymers for inhibiting autoimmune diseases and methods of use thereof |
EP1688486B1 (en) * | 2003-10-29 | 2016-12-14 | Toagosei Co., Ltd. | Antibacterial peptide and utilization of the same |
US7655221B2 (en) | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
GB0818074D0 (en) * | 2008-10-02 | 2008-11-05 | Lytix Biopharma As | Treatment of biofilms |
WO2010080819A1 (en) | 2009-01-06 | 2010-07-15 | C3 Jian, Inc. | Targeted antimicrobial moieties |
EP2444105A4 (en) * | 2009-06-16 | 2013-08-21 | Univ Tokai | Anti-gram-negative bacteria agent |
CN103221383B (en) * | 2010-08-27 | 2016-04-20 | 株式会社新药 | Promote the new compound of human antibiotic peptide secretion, its preparation method and contain its composition as activeconstituents |
WO2013124436A1 (en) * | 2012-02-23 | 2013-08-29 | University Of East London | Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains |
CA2888068A1 (en) * | 2014-04-15 | 2015-10-15 | The Hospital For Sick Children | Cationic antimicrobial peptides |
IT202000006481A1 (en) * | 2020-03-27 | 2021-09-27 | Sanidrink S R L | Antimicrobial tubular ducts |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997018826A1 (en) * | 1995-11-22 | 1997-05-29 | Intrabiotics Pharmaceuticals, Inc. | Fine tuned protegrins |
WO1998007745A2 (en) * | 1996-08-21 | 1998-02-26 | Micrologix Biotech, Inc. | Compositions and methods for treating infections using analogues of indolicidin |
WO1999065506A2 (en) * | 1998-06-12 | 1999-12-23 | Micrologix Biotech Inc. | Cancer therapy with indolicidin or cationic peptides and their polymer conjugates |
US6043220A (en) * | 1997-12-03 | 2000-03-28 | Intrabiotics Pharmaceuticals, Inc. | Threonine-containing protegrins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714577A (en) * | 1996-01-26 | 1998-02-03 | University Of Pittsburgh | Antimicrobial peptides |
AU720405B2 (en) * | 1996-02-16 | 2000-06-01 | Regents Of The University Of California, The | Antimicrobial peptides and methods of use |
US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
-
2002
- 2002-06-21 AU AU2002317071A patent/AU2002317071B2/en not_active Ceased
- 2002-06-21 CA CA2451310A patent/CA2451310C/en not_active Expired - Lifetime
- 2002-06-21 JP JP2003506921A patent/JP2004534084A/en active Pending
- 2002-06-21 US US10/481,286 patent/US20040235745A1/en not_active Abandoned
- 2002-06-21 CN CNA028121910A patent/CN1516598A/en active Pending
- 2002-06-21 EP EP02744972A patent/EP1401478A2/en not_active Withdrawn
- 2002-06-21 WO PCT/CA2002/000936 patent/WO2003000277A2/en active Application Filing
- 2002-06-21 IL IL15927402A patent/IL159274A0/en unknown
-
2003
- 2003-12-10 ZA ZA200309580A patent/ZA200309580B/en unknown
-
2007
- 2007-06-11 US US11/761,117 patent/US20080234188A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997018826A1 (en) * | 1995-11-22 | 1997-05-29 | Intrabiotics Pharmaceuticals, Inc. | Fine tuned protegrins |
WO1998007745A2 (en) * | 1996-08-21 | 1998-02-26 | Micrologix Biotech, Inc. | Compositions and methods for treating infections using analogues of indolicidin |
US6043220A (en) * | 1997-12-03 | 2000-03-28 | Intrabiotics Pharmaceuticals, Inc. | Threonine-containing protegrins |
WO1999065506A2 (en) * | 1998-06-12 | 1999-12-23 | Micrologix Biotech Inc. | Cancer therapy with indolicidin or cationic peptides and their polymer conjugates |
Non-Patent Citations (3)
Title |
---|
HANCOCK R E W ET AL: "Cationic peptides: a new source of antibiotics", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 16, no. 2, 1 February 1998 (1998-02-01), pages 82 - 88, XP004107047, ISSN: 0167-7799 * |
LIU LI-PING ET AL: "Threshold hydrophobicity dictates helical conformations of peptides in membrane environments.", BIOPOLYMERS, vol. 39, no. 3, 1996, pages 465 - 470, XP009004885, ISSN: 0006-3525 * |
STARK MARGARETA ET AL: "Cationic hydrophobic peptides with antimicrobial activity.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 46, no. 11, November 2002 (2002-11-01), November, 2002, pages 3585 - 3590, XP009004888, ISSN: 0066-4804 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003000277A2 (en) | 2003-01-03 |
ZA200309580B (en) | 2004-07-28 |
AU2002317071B2 (en) | 2008-01-31 |
CN1516598A (en) | 2004-07-28 |
CA2451310C (en) | 2014-02-25 |
JP2004534084A (en) | 2004-11-11 |
US20040235745A1 (en) | 2004-11-25 |
EP1401478A2 (en) | 2004-03-31 |
IL159274A0 (en) | 2004-06-01 |
CA2451310A1 (en) | 2003-01-03 |
US20080234188A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2202058A1 (en) | Cyclic hexapeptides having antibiotic activity | |
WO2003077828A3 (en) | Novel florfenicol-type antibiotics | |
EP0665754A4 (en) | Antimicrobial peptides. | |
WO2000018355A3 (en) | Use of purified invaplex from gram negative bacteria as a vaccine | |
WO2005019241A3 (en) | Cationic antimicrobial peptides and compositions thereof | |
WO2003000277A3 (en) | Antimicrobial peptides | |
CA2258906A1 (en) | Amides | |
AU1747201A (en) | Compounds with antibacterial and antiparasitic properties | |
WO2003030886A3 (en) | Allylamides useful in the treatment of alzheimer's disease | |
WO2005018650A3 (en) | Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent | |
WO2002090502A3 (en) | Highly conserved proteins from gram-positive bacteria | |
AU2858399A (en) | A novel antimicrobial peptide isolated from (parasilurus asotus) and its uses | |
WO1998056398A3 (en) | A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon | |
WO2002000687A3 (en) | Antimicrobial peptides and methods of use thereof | |
ZA861424B (en) | Basic monocarboxyamide derivatives of actagardine having antibiotic activity | |
CA2250630A1 (en) | Novel lantibiotic related to actagardine, and processes for the preparation and use thereof | |
WO2004056849B1 (en) | Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria | |
WO2004043928A3 (en) | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents | |
WO2001081372A3 (en) | Vancomycin analogs | |
HK1067531A1 (en) | A pharmaceutical composition for treating hiv infection | |
EP0781141A4 (en) | Aza cyclohexapeptide compounds | |
EP0365319A3 (en) | Glycopeptide antibiotics | |
EP2210597A3 (en) | Bacterial virulence modifying agents | |
CA2135200A1 (en) | Canine coronavirus s gene and uses therefor | |
WO2005011587A3 (en) | Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 159274 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/09580 Country of ref document: ZA Ref document number: 200309580 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002317071 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 530186 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 028121910 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2451310 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003506921 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002744972 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002744972 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10481286 Country of ref document: US |